WGS•benzinga•
Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $80
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 19, 2025 by benzinga